Study Type | First Author | Year | Sample size | Age | Country | Target | Scale | NOS Score | |
---|---|---|---|---|---|---|---|---|---|
Depression | MetS | ||||||||
Cross-sectional studies | Ko [23] | 2019 | 9867 | ≥ 19 | Korea | General population | PHQ-9 | ATP III | 8 |
Moreira [20] | 2019 | 545 | 18–24 | Brazil | Young adults | Interview | ATP III | 6 | |
Chattopadhyay [32] | 2018 | 97 | - | India | Primary care patients | BDI | ATP III | 7 | |
Bakhtiari [43] | 2018 | 1560 | 69.3 ± 7.4 | Iran | Elderly people | GSD | ATP III | 7 | |
Mattei [44] | 2018 | 129 | 40–80 | Italy | Primary care patients | HADS | ATP III | 7 | |
Kim [24] | 2018 | 10,459 | - | Korea | General population | PHQ-9 | ATP III | 7 | |
Moreira [21] | 2017 | 972 | 25.8 ± 2.1 | Brazil | General population | Interview | ATP III | 7 | |
Ra [25] | 2017 | 1938 | ≥ 40 | Korea | Men | Interview | ATP III | 7 | |
2404 | Women | 7 | |||||||
Yu [11] | 2017 | 11,430 | ≥ 35 | China | General population | PHQ-9 | ATP III | 8 | |
Chang [12] | 2017 | 11,258 | - | Taiwan | General population | MHI-5 | WHO | 8 | |
Cardenas [45] | 2017 | 332 | ≥ 60 | USA | Elderly | PHQ-9 | WHO | 8 | |
Park [26] | 2016 | 23,385 | 46.13 ± 0.18 | Korea | Women | Interview | ATP III | 8 | |
Agarwal [40] | 2016 | 150 | - | India | psychiatric Outpatient | Interview | ATP III | 7 | |
Ribeiro [22] | 2015 | 226 | 23–66 | Brazil | Nursing personnel | HADS | ATP III | 7 | |
Kahl [46] | 2015 | 163 | - | Germany | Primary care patients | Interview | ATP III | 7 | |
Vargas [3] | 2014 | 342 | - | Brazil | General population | Interview | IDF | 7 | |
Butnoriene [47] | 2014 | 1115 | 62 ± 9.6 | Lithuania | General population | Interview | ATP III | 7 | |
Takeuchi [38] | 2013 | 1011 | 41.1 ± 8.1 | Japan | General population | Interview | IDF | 8 | |
1011 | 42.3 ± 8.7 | 8 | |||||||
Sekita [13] | 2013 | 1353 | 63 | Japan | Men | CES-D | ATP III | 7 | |
2013 | 1760 | 62 | Women | 7 | |||||
Marijnissen | 2013 | 1277 | 61.1 ± 5.9 | Netherlands | General population | BDI-I | IDF | 7 | |
Demirci [48] | 2011 | 250 | - | Turkey | General population | BDI | ATP III | 7 | |
Foley [8] | 2010 | 2525 | - | Australia | General population | Interview | ATP III | 8 | |
Ahola [41] | 2010 | 1226 | 45 ± 12 | Finland | Diabetes type I | BDI | ATP III | 8 | |
Hildrum [9] | 2009 | 9571 | 47.74 | Norway | General population | HADS | IDF | 8 | |
Takeuchi [1] | 2009 | 1215 | 42.5 | Japan | Office workers | POMS | IDF | 8 | |
Toker [36] | 2008 | 1525 | 20–75 | Israel | Women | PHQ-9 | ATP III | 7 | |
2355 | 20–75 | Men | 7 | ||||||
Miettola [49] | 2008 | 416 | 50.4 ± 10.5 | Finland | General population | BDI | ATP III | 6 | |
Dunbar [50] | 2008 | 1345 | 25–84 | Australia | General population | HADS | ATP III | 7 | |
Vogelzangs [51] | 2007 | 867 | 74.1 ± 6.6 | Italy | General population | CES-D | ATP III | 7 | |
Skilton [52] | 2007 | 1598 | 51.8 ± 9.8 | France | Primary care patients | HADS | ATP III | 7 | |
Kinder [37] | 2004 | 3003 | 28.7 | USA | Women | Interview | ATP III | 7 | |
3186 | 28.2 | Men | 7 | ||||||
Cohort studies | Dregan [34] | 2020 | 71,799 | - | United Kingdom | Women | Interview | ATP III | 8 |
52,646 | - | Men | 8 | ||||||
Matta [4] | 2019 | 64,861 | 46.30 | France | General population | CES-D | IDF | 7 | |
van Leijden [2] | 2018 | 21,182 | 44.2 ± 13.2 | Netherlands | Multi-ethnic | PHQ-9 | IDF | 7 | |
Rethorst [27] | 2017 | 47,702 | - | USA | General population | Interview | ATP III | 7 | |
Marriana [53] | 2017 | 1172 | 62 | Finland | General population | CES-D | ATP III | 7 | |
Matthew [28] | 2016 | 1743 | 52.5 | USA | General population | CES-D | ATP III | 7 | |
Renel [29] | 2015 | 1798 | 43.3 | USA | General population | CES-D | ATP III | 7 | |
Akbaraly [54] | 2011 | 4446 | ≥ 65 | France | Elderly | CES-D | ATP III | 7 | |
East [7] | 2010 | 1688 | 47.6 ± 10.3 | USA | Women | CES-D | ATP III | 7 | |
3437 | 49.3 ± 10.2 | Men | 7 | ||||||
Akbaraly [42] | 2009 | 5232 | 49.5 ± 6.1 | France | Office staff | GHQ | ATP III | 8 | |
Goldbacher [30] | 2009 | 429 | 45.6 | USA | Women | DSM-IV | ATP III | 7 | |
Vogelzangs [10] | 2009 | 1212 | 55–85 | Netherlands | General population | CES-D | ATP III | 8 | |
Vanhala [39] | 2009 | 294 | 45.9 | Finland | Women | BDI | ATP III | 6 | |
194 | 46 | Men | 6 | ||||||
Viinamaki [35] | 2009 | 223 | - | Finland | General population | DSM-IV | ATP III | 6 | |
Vaccarino [31] | 2008 | 652 | - | USA | Cardiovascular disease | BDI | ATP III | 7 | |
Katri [55] | 2007 | 432 | 49 | Finland | General population | BDI | ATP III | 7 | |
Gil [56] | 2006 | 795 | - | Poland | General population | BDI | ATP III | 7 | |
Herva [57] | 2006 | 5691 | - | Finland | General population | HSCL-25 | ATP III | 8 |